Report
GlobalData Healthcare Department
EUR 115.88 For Business Accounts Only

Bird Rock Bio Inc - Company Review

Bird Rock Bio Inc - Company Review

Summary

Bird Rock Bio Inc (Bird Rock Bio), formerly RuiYi Inc is a clinical stage biopharmaceutical company that develops immuno-inflammatory regulators. The company’s products under development include RYI-018 is a peripheral antagonist antibody to cannabinoid receptor 1 intended for the treatment of nonalcoholic steatohepatitis, fibrotic and metabolic diseases. Its Gerilimzumab, an anti IL-6 antibody indicated for moderate to severe rheumatoid arthritis, inflammatory and autoimmune diseases. Bird Rock Bio provides therapeutic antibodies, with clinical and commercial differentiation, against biologic targets. The company operates through research institutes and universities for its activities. Bird Rock Bio is headquartered in La Jolla, California, the US.

This comprehensive company report of Bird Rock Bio Inc provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Analysts
GlobalData Healthcare Department

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch